コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tly declared a global health priority by the World Health Organization.
2 e "drugs for bad bugs", as identified by the World Health Organization.
3 n urgent need for therapeutic development by World Health Organization.
4 measles cases from 2013-2018 reported to the World Health Organization.
5 ity Periodontal Index (CPI) developed by the World Health Organization.
6 riteria for PIMS-TS from the UK, the US, and World Health Organization.
7 19 was officially declared a pandemic by the World Health Organization.
8 sistance, and is a priority organism for the World Health Organization.
9 been deemed a high-priority pathogen by the World Health Organization.
10 ature and the current global strategy by the World Health Organization.
11 a tasty way to follow the recommendations of World Health Organization.
12 rity diagnostic need for tuberculosis by the World Health Organization.
13 blood, a limit of detection suggested by the World Health Organization.
14 ug susceptibility testing recommended by the World Health Organization.
15 d was recently declared as a pandemic by the World Health Organization.
16 in conjunction with incidence data from the World Health Organization.
17 which is classified as a threat agent by the World Health Organization.
18 atic filariasis (LF) is a major focus of the World Health Organization.
19 e, WNT, Group 3, and Group 4, defined by the World Health Organization.
20 800-130.000 deaths per year according to the World Health Organization.
23 been recognized as a promoter of health, the World Health Organization 2014 report on non-communicabl
24 M1 is recognized as a separate entity in the World Health Organization 2016 classification and carrie
26 e global survival target recently set by the World Health Organization: 60% survival for all children
27 o key antibiotics, especially those from the World Health Organization Access group, is needed throug
29 of 'next-generation' nets recommended by the World Health Organization against resistant vectors.
32 practice guidelines and as supported by the World Health Organization and contemporary literature.
33 S-CoV-2) was classified as a pandemic by the World Health Organization and has caused over 550,000 de
34 nters for Disease Control and Prevention and World Health Organization and mandated by the Joint Comm
35 CrAg-positive persons are recommended by the World Health Organization and many national HIV guidelin
36 roliferative/myelodysplastic neoplasm by the World Health Organization and shares some features with
38 f the top ten threats to human health by the World Health Organization, and new technologies are urge
39 ad use of vaccines, which are defined by the World Health Organization as "biological preparations th
42 ed infections and has been recognised by the World Health Organization as one of the most threatening
52 Q) has been reported worldwide, although the World Health Organization clinical drug efficacy studies
53 ed that participants with more advanced HIV (World Health Organization clinical stage 3 or 4) disease
56 mes, including maternal near-miss defined by World Health Organization, cortical blindness/retinal de
57 ories and outcomes, categorized by using the World Health Organization COVID-19 disease severity scal
58 st 60 years old who have anemia according to World Health Organization criteria (n = 676) and 1:1 mat
60 tentially life-threatening conditions (using World Health Organization criteria) in pregnancy, childb
64 highlight potential limitations of the 2013 World Health Organization criterion for studying pneumoc
67 owing an unprecedented global spread(3), the World Health Organization declared COVID-19 a pandemic o
70 children aged 1-59 months hospitalized with World Health Organization defined severe or very severe
73 Central and South Auckland hospitalized for World Health Organization-defined severe acute respirato
74 ined SAD among presumed SCDs and suggest the World Health Organization definition can be improved by
79 by 2 European clinicians and scientists, the World Health Organization Director General has declared
80 concentrations exceeded the 0.1-0.2 mg L(-1) World Health Organization drinking water guidelines in a
81 Western Pacific and European Regions of the World Health Organization during their exposure periods.
85 TB lipoarabinomannan antigen (LAM-test) is a World Health Organization-endorsed point-of-care urine t
92 tion is a moderate priority according to the World Health Organization for presbyopia correction serv
93 We analyzed mortality data submitted to the World Health Organization from 2005 to 2015 by individua
96 [1.59; 1.08-2.33; P = .02], as compared with World Health Organization Global Burden of Disease high-
97 five institutions with lower-grade gliomas (World Health Organization grade II and III) were used in
98 vely evaluated 127 consecutive patients with World Health Organization grade II-IV glioma who underwe
99 newly diagnosed previously untreated glioma (World Health Organization grade II-IV) and healthy volun
100 predicted isocitrate dehydrogenase status in World Health Organization grade II/III gliomas on the ba
101 atients with IDH-mutant lower-grade gliomas (World Health Organization grade II/III) and 1p/19q codel
103 The 1-y OS rates were 88%, 71%, and 52% for World Health Organization grades I, II, and III, respect
104 The 6-mo PFS rates were 94%, 48%, and 0% for World Health Organization grades I, II, and III, respect
105 k aimed to grade the tumors according to the World Health Organization grading system adopted in 2004
107 ation-weighted mean concentrations below the World Health Organization guideline for annual average P
114 y is rapidly increasing, so much so that the World Health Organization has declared obesity as a glob
121 isted in the most dangerous pathogens by the World Health Organization, has 12-30% fatality rates wit
122 e to this threat, the United Nations and the World Health Organization have called for multisectoral,
127 id conjugate vaccine was prequalified by the World Health Organization in 2017 and is beginning to be
129 provisional bedaquiline MIC breakpoints and World Health Organization interim critical concentration
130 EMBASE, MEDLINE, Clinicaltrials.gov, and the World Health Organization International Clinical Trials
135 th Cu and was lowered by nCuO below the WHO (World Health Organization) maximum safe concentration fo
136 er Incidence in 5 Continents series, and the World Health Organization mortality database from 1960 o
142 representing vaccine strains selected by the World Health Organization or a set of viral variants tha
145 rganization scores were available, 39% had a World Health Organization performance score of 0-1 3 mon
147 of Met-lead 1.44 M1 is five times below the World Health Organization-permitted level of lead in tap
148 s epidemiological data are important for the World Health Organization plan of eliminating viral hepa
149 ch on typhoid conjugate vaccines (TCVs), the World Health Organization prequalification of a TCV, and
150 f Experts on Immunization recommendation and World Health Organization prequalification should make t
153 ing Scale, Hamilton Depression Rating Scale, World Health Organization Quality of Life Scale-Brief Ve
155 ticipants were asked to complete the 26-item World Health Organization Quality of Life-BREF (WHOQOL-B
156 ML) with inv(3)/t(3;3)(q21q26) is a distinct World Health Organization recognized entity, characteriz
157 towards typhoid fever control with a strong World Health Organization recommendation and the approva
158 national measles vaccination rates above the World Health Organization recommendation of 95% coverage
159 e still using oral co-trimoxazole, despite a World Health Organization recommendation of oral amoxici
161 A conjugate vaccine (MACV) in the belt, the World Health Organization recommended case-based meningi
165 tion in ocular chlamydia prevalence than the World Health Organization-recommended annual treatment p
166 in resource-limited settings treated with 3 World Health Organization-recommended antiretroviral (AR
167 immunodeficiency virus (HIV) infection is a World Health Organization-recommended standard of care i
182 nate regimen was noninferior to the existing World Health Organization regimen across the patient pop
183 sed on age, vaccination history, onset year, World Health Organization region, and World Bank income
188 idly gather the evidence necessary to inform World Health Organization review and to support potentia
189 elated mortality are required to realize the World Health Organization's "End Tuberculosis Strategy."
191 impact and the feasibility of achieving the World Health Organization's (WHO) target of reducing gon
192 Most countries have formally adopted the World Health Organization's 2015 recommendation of unive
193 ns between 2015 and 2035, as targeted by the World Health Organization's End TB Strategy ("effective
195 s that have recently been implemented in the World Health Organization's Expanded Programme on Immuni
197 o (DRC), remain a challenge to achieving the World Health Organization's goal of global elimination o
198 few nanomolar (<3 nM), which is close to the World Health Organization's guideline for the maximum co
199 edical specialists and categorized using the World Health Organization's International Classification
201 (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization's List of Essential Medication
203 ncentrations that approached or exceeded the World Health Organization's risk level for arsenic (6.6
204 for trichiasis is one of the pillars of the World Health Organization's strategy for global eliminat
205 size that high-quality implementation of the World Health Organization's Surgical Safety Checklist (S
206 ure all cases of IMD, in accordance with the World Health Organization's updated vaccine-preventable
209 vent more than 7 million deaths by 2030, the World Health Organization set goals to eliminate HBV and
210 ment was assessed on the basis of a modified World Health Organization six-point ordinal scale and la
212 All CXRs were analyzed according to the World Health Organization Standardization of Interpretat
213 age z scores were generated according to the World Health Organization standards and the Fenton growt
216 met or approached the benchmarks set out in World Health Organization target product profiles for no
218 stance in Anopheles gambiae s.l. exceeds the World Health Organization thresholds for susceptibility
219 nown pathogen, 'Disease X', suggested by the World Health Organization to be a potential cause of a f
220 of multidrug-resistant strains, leading the World Health Organization to declare A. baumannii a "Pri
221 Here we use publicly available data from the World Health Organization to generate retrospective fore
222 ve bacterial diseases has been set up by the World Health Organization to provide disease burden data
223 ival is still poor, and projections from the World Health Organization underscore the need to improve
224 level, the Food and Agriculture Organization/World Health Organization/United Nations University (FAO
225 (TCV) that was recently prequalified by the World Health Organization was shown to be efficacious in
229 jugate vaccine (Vi-TCV), prequalified by the World Health Organization (WHO) and highly immunogenic i
230 <93% oxygen saturation (SpO2) thresholds and World Health Organization (WHO) and Malawi clinical guid
231 ntrations above the maximum limit set by the World Health Organization (WHO) and the UN Food and Agri
234 India needs to act more aggressively as the World Health Organization (WHO) annual air quality guide
235 .0 mug/m3, which were well below the current World Health Organization (WHO) annual standard (10 mug/
236 eglected tropical diseases identified by the World Health Organization (WHO) are limited by one or mo
238 (sBMD) at the lumbar spine and femoral neck, World Health Organization (WHO) BMD categories at both s
240 recognized as a distinct entity in the 2017 World Health Organization (WHO) classification of hemato
242 ch used the World Heart Federation (WHF) and World Health Organization (WHO) criteria, respectively.
248 panding geographic scale of the disease, the World Health Organization (WHO) declared the COVID-19 ou
249 e functional visual acuity (VA) based on the World Health Organization (WHO) definition of 'low visio
251 We model what intervention can achieve the World Health Organization (WHO) elimination target of an
252 ning and treatment is a key component of the World Health Organization (WHO) EndTB Strategy, but the
253 Unpublished studies were identified by the World Health Organization (WHO) Evidence Review Group (E
254 ours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III t
255 d from July 2008 to February 2019, untreated World Health Organization (WHO) grade II/III gliomas wer
256 Here, we analyzed 160 tumors from all 3 World Health Organization (WHO) grades (I through III) u
260 F assay (Cepheid, Sunnyvale, CA, USA) by the World Health Organization (WHO) in 2010, Viet Nam's Nati
269 charide (ViPS) and Ty21a vaccines have had a World Health Organization (WHO) recommendation for progr
279 nd routine immunization data reported to the World Health Organization (WHO) Regional Office for Afri
281 on of "a world free of schistosomiasis," the World Health Organization (WHO) set ambitious goals of c
282 ions Development Programme (UNDP)/World Bank/World Health Organization (WHO) Special Programme for Re
283 s (4-24 and >24 months after ART start), and World Health Organization (WHO) stage among naive ART in
284 Data were extracted from national-level World Health Organization (WHO) Stepwise Approach to Sur
285 aying (TIRS) experiments; trial outcomes and World Health Organization (WHO) testing guidance for the
286 d this worrying development has prompted the World Health Organization (WHO) to publish a vector aler
287 aseline IgG anti-HEV levels from 1.5 to 13.4 World Health Organization (WHO) U/mL evidenced reinfecti
288 ating clear and consistent reporting via the World Health Organization (WHO) viral hepatitis monitori
290 by droplets and the guidelines issued by the World Health Organization (WHO), US Center for Diseases
292 rescription rate for ill children and in all World Health Organization (WHO)-recommended perinatal ca
298 or other interventions (current coverage and World Health Organization [WHO] Global Technical Strateg